Pharmacological Optimization of PSMA-Based Radioligand Therapy

Pharmacological Optimization of PSMA-Based Radioligand Therapy

Prostate cancer (PCa) is the most common malignancy in men of middle and older age. The standard treatment strategy for PCa ranges from active surveillance in low-grade, localized PCa to radical prostatectomy, external beam radiation therapy, hormonal treatment and chemotherapy. Recently, the use of...

Full description

Bibliographic Details
Main Authors: Suzanne van der Gaag, Imke H. Bartelink, André N. Vis, George L. Burchell, Daniela E. Oprea-Lager, Harry Hendrikse
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Biomedicines
Subjects:
PSMA
prostate cancer
radioligand
therapy
theranostics
optimization
Online Access:https://www.mdpi.com/2227-9059/10/12/3020

Internet

https://www.mdpi.com/2227-9059/10/12/3020

Similar Items